BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 3202501)

  • 1. The pulmonary effects of buthionine sulfoximine treatment and glutathione depletion in rats.
    Coursin DB; Cihla HP
    Am Rev Respir Dis; 1988 Dec; 138(6):1471-9. PubMed ID: 3202501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation to chronic hyperoxia. Biochemical effects and the response to subsequent lethal hyperoxia.
    Coursin DB; Cihla HP; Will JA; McCreary JL
    Am Rev Respir Dis; 1987 May; 135(5):1002-6. PubMed ID: 3579000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
    Miranda AF; Wiley MJ; Wells PG
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
    Mitchell JB; Russo A; Biaglow JE; McPherson S
    Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
    Sun JD; Ragsdale SS; Benson JM; Henderson RF
    Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP; Epp ER; Biaglow JE; Morse-Gaudio M; Zachgo E
    Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
    Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
    Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD; Maines MD
    Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-acetyl-cysteine, D-penicillamine and buthionine sulfoximine on glutathione levels and CNS oxygen toxicity in rats.
    Lalitha T; Kerem D; Yannai S
    Pharmacol Toxicol; 1990 Jan; 66(1):56-61. PubMed ID: 2308909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of thiols in cellular response to radiation and drugs.
    Biaglow JE; Varnes ME; Clark EP; Epp ER
    Radiat Res; 1983 Sep; 95(3):437-55. PubMed ID: 6684310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of intracellular GSH and NPSH by buthionine sulfoximine and diethyl maleate: factors that influence enhancement of aerobic radiation response.
    Varnes ME; Biaglow JE; Roizin-Towle L; Hall EJ
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1229-33. PubMed ID: 6469743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats.
    Manning BW; Franklin MR; Galinsky RE
    Drug Metab Dispos; 1991; 19(2):498-502. PubMed ID: 1676661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buthionine sulfoximine-induced glutathione depletion. Its effect on antioxidants, lipid peroxidation and calcium homeostasis in the lung.
    Thanislass J; Raveendran M; Devaraj H
    Biochem Pharmacol; 1995 Jul; 50(2):229-34. PubMed ID: 7632167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of silica-induced lung injury by reducing lung non-protein sulfhydryls with buthionine sulfoximine.
    Lombard-Gillooly K; Hubbard AK
    Toxicol Lett; 1993 Mar; 66(3):305-15. PubMed ID: 8386403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.